Eiger BioPharmaceuticals Inc. (EIGR) Gained 5.27% or 0.7 To Price $13.99 On Monday


Eiger BioPharmaceuticals Inc. (EIGR) gained 5.27% or 0.7 to $13.99. It is approximately 78962 shares traded, which is 97.36% compare to the average total volume 81103. The market cap of EIGR is $269.45 million. The year to date change is 34.17%. The 52 week price range is from $8.2 to $18.0. Price of EIGR have changed 1.14% during last week. It have changed 0.83% over last month, 26.69% over last 3 months, 13.59% over last 6 months and 39.89% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for EIGR is 13.37. It is -4.43% below current price. The 200-day Moving Averages for EIGR is 12.03. It is -14.01% below current price. The 52-week High is 18.0. It is 28.66% from the current price. The 52-week Low is 8.2. It is -41.39% from current price.

There are some statistics of EIGR. It is has market cap $269.45 million. The share outstanding is 19.26 million. The average volume is 81103. The percent of top 15 Institution holding is 82.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of EIGR is -201.99%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of EIGR is -92.95%.


Tags:

Share this post